TRANSKARYOTIC THERAPIES INC (CIK: 0000885259) EDGAR, Information, Filings... CompaniesBIO.Com

TRANSKARYOTIC THERAPIES INC

Mailing address
, , Delaware,
Phone
6173490200
State location
Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

TRANSKARYOTIC THERAPIES INC (CIK: 0000885259) is an American company incorporated in the state of Massachusetts. Head office is located at 195 ALBANY ST, CAMBRIDGE, Massachusetts, 02139. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). TRANSKARYOTIC THERAPIES INC is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Pauwels Eric	0001323212	Apr-13-2005	officer: Sr. VP - Global Commercial Ops
Kirby Neil	0001308655	Nov-11-2004	officer: Sr VP, Strategic Prod Devlpmt.
ASTRUE MICHAEL J	0001236367	Mar-24-2004	director, officer: President & CEO
PERRY GREGORY D	0001236371	Mar-24-2004	officer: VP, Finance & CEO
VILLA KOMAROFF LYDIA	0001274224	Nov-30-2003	director
LANGER DENNIS	0001274225	Nov-30-2003	director
MILLER WILLIAM R	0001073380	Jul-01-2003	director
THOMAS JAMES E	0001204789	Jul-01-2003	director
YETTER WAYNE P	0001215120	Jul-01-2003	director
GILBERT WALTER PHD	0001236368	Jul-01-2003	director
PENDERGAST DAVID D PHD	0001236370	Mar-28-2003	officer: Senior VP Manufacturing
FUCHS RENATO	0001236372	Mar-28-2003	officer: COO and Executive VP

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by TRANSKARYOTIC THERAPIES INC

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-06-009041 (34 Act) Size: KB	Feb-14-2006	005-47221 06608673
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000895345-06-000169 (34 Act) Size: KB	Feb-13-2006	005-47221 06602814
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000312069-06-001924 (34 Act) Size: KB	Feb-10-2006	005-47221 06595010
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-05-035143 ( Act) Size: 0 KB	Jul-29-2005
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-05-035141 ( Act) Size: 0 KB	Jul-29-2005
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-05-035139 ( Act) Size: 0 KB	Jul-29-2005
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-05-035138 ( Act) Size: 0 KB	Jul-29-2005
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-05-035137 ( Act) Size: 0 KB	Jul-29-2005
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-05-035134 ( Act) Size: 0 KB	Jul-29-2005
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-05-035133 ( Act) Size: 0 KB	Jul-29-2005
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-05-035132 ( Act) Size: 0 KB	Jul-29-2005
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-05-035131 ( Act) Size: 0 KB	Jul-29-2005
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0000950135-05-004212 (34 Act) Size: KB	Jul-28-2005	000-21481 05978948
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0000950135-05-004108 (34 Act) Size: KB	Jul-22-2005	000-21481 05967905
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000928475-05-000179 (34 Act) Size: KB	Jul-21-2005	005-47221 05966904
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0000950135-05-004095 (34 Act) Size: KB	Jul-21-2005	000-21481 05966523
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0000950135-05-003999 (34 Act) Size: KB	Jul-20-2005	000-21481 05963920
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0000919574-05-002315 (34 Act) Size: KB	Jul-19-2005	005-47221 05960499
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0000950135-05-003976 (34 Act) Size: KB	Jul-18-2005	000-21481 05960051
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000899140-05-000672 (34 Act) Size: KB	Jul-18-2005	005-47221 05959916

Recent 20 filings. View all TRANSKARYOTIC THERAPIES INC filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

TRANSKARYOTIC THERAPIES INC overview
TRANSKARYOTIC THERAPIES INC job
TRANSKARYOTIC THERAPIES INC stock
TRANSKARYOTIC THERAPIES INC ownership
TRANSKARYOTIC THERAPIES INC CEO
TRANSKARYOTIC THERAPIES INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.